Associated Papers
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.
Chheda ZS et al.
The Journal of Experimental Medicine, 2018
29203539 (PubMed )
Supplement: JEM_20171046_sm.pdf
Select a paper to view details